194 related articles for article (PubMed ID: 23518404)
21. Early impact of sequential introduction of 7-valent and 13-valent pneumococcal conjugate vaccine on IPD in Israeli children <5 years: an active prospective nationwide surveillance.
Ben-Shimol S; Greenberg D; Givon-Lavi N; Schlesinger Y; Somekh E; Aviner S; Miron D; Dagan R
Vaccine; 2014 Jun; 32(27):3452-9. PubMed ID: 24690148
[TBL] [Abstract][Full Text] [Related]
22. Nearly complete elimination of the 7-valent pneumococcal conjugate vaccine serotypes in Tennessee.
Halasa NB; Grijalva CG; Arbogast PG; Talbot TR; Craig AS; Griffin MR; Schaffner W
Pediatr Infect Dis J; 2013 Jun; 32(6):604-9. PubMed ID: 23348816
[TBL] [Abstract][Full Text] [Related]
23. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
[TBL] [Abstract][Full Text] [Related]
24. Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.
Lepoutre A; Varon E; Georges S; Dorléans F; Janoir C; Gutmann L; Lévy-Bruhl D; ;
Vaccine; 2015 Jan; 33(2):359-66. PubMed ID: 25448105
[TBL] [Abstract][Full Text] [Related]
25. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK; Shea KM; Stevenson AE; Pelton SI;
Pediatr Infect Dis J; 2010 Apr; 29(4):289-93. PubMed ID: 19935447
[TBL] [Abstract][Full Text] [Related]
26. Streptococcus pneumoniae serotypes in Utah adults at the end of the PCV7 era.
Kendall BA; Dascomb KK; Mehta RR; Mason EO; Ampofo K; Pombo DJ; Pavia AT; Byington CL
Vaccine; 2011 Nov; 29(49):9123-6. PubMed ID: 22001280
[TBL] [Abstract][Full Text] [Related]
27. Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines.
Shouval DS; Greenberg D; Givon-Lavi N; Porat N; Dagan R
Pediatr Infect Dis J; 2009 Apr; 28(4):277-82. PubMed ID: 19258924
[TBL] [Abstract][Full Text] [Related]
28. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.
Moore MR; Link-Gelles R; Schaffner W; Lynfield R; Lexau C; Bennett NM; Petit S; Zansky SM; Harrison LH; Reingold A; Miller L; Scherzinger K; Thomas A; Farley MM; Zell ER; Taylor TH; Pondo T; Rodgers L; McGee L; Beall B; Jorgensen JH; Whitney CG
Lancet Infect Dis; 2015 Mar; 15(3):301-9. PubMed ID: 25656600
[TBL] [Abstract][Full Text] [Related]
29. Dynamics of Severe and Non-severe Invasive Pneumococcal Disease in Young Children in Israel Following PCV7/PCV13 Introduction.
Glikman D; Dagan R; Barkai G; Averbuch D; Guri A; Givon-Lavi N; Ben-Shimol S;
Pediatr Infect Dis J; 2018 Oct; 37(10):1048-1053. PubMed ID: 29750768
[TBL] [Abstract][Full Text] [Related]
30. Impact of pneumococcal conjugate vaccine (PCV7 and PCV13) on pneumococcal invasive diseases in Italian children and insight into evolution of pneumococcal population structure.
Camilli R; D'Ambrosio F; Del Grosso M; Pimentel de Araujo F; Caporali MG; Del Manso M; Gherardi G; D'Ancona F; Pantosti A;
Vaccine; 2017 Aug; 35(35 Pt B):4587-4593. PubMed ID: 28716556
[TBL] [Abstract][Full Text] [Related]
31. Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.
Sharma D; Baughman W; Holst A; Thomas S; Jackson D; da Gloria Carvalho M; Beall B; Satola S; Jerris R; Jain S; Farley MM; Nuorti JP
Pediatr Infect Dis J; 2013 Feb; 32(2):e45-53. PubMed ID: 23080290
[TBL] [Abstract][Full Text] [Related]
32. Have changing pneumococcal vaccination programmes impacted disease in Ontario?
Lim GH; Wormsbecker AE; McGeer A; Pillai DR; Gubbay JB; Rudnick W; Low DE; Green K; Crowcroft NS; Deeks SL
Vaccine; 2013 May; 31(24):2680-5. PubMed ID: 23597716
[TBL] [Abstract][Full Text] [Related]
33. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.
Pilishvili T; Lexau C; Farley MM; Hadler J; Harrison LH; Bennett NM; Reingold A; Thomas A; Schaffner W; Craig AS; Smith PJ; Beall BW; Whitney CG; Moore MR;
J Infect Dis; 2010 Jan; 201(1):32-41. PubMed ID: 19947881
[TBL] [Abstract][Full Text] [Related]
34. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
[TBL] [Abstract][Full Text] [Related]
35. Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
Cho EY; Choi EH; Kang JH; Kim KH; Kim DS; Kim YJ; Ahn YM; Eun BW; Oh SH; Cha SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Kim JH; Lee H; Lee T; Kim HM; Lee KS; Kim CS; Park SE; Kim YM; Oh CE; Ma SH; Jo DS; Choi YY; Lee J; Bae GR; Park O; Park YJ; Kim ES; Lee HJ
J Korean Med Sci; 2016 Jul; 31(7):1082-8. PubMed ID: 27366006
[TBL] [Abstract][Full Text] [Related]
36. Sex differences in invasive pneumococcal disease and the impact of pneumococcal conjugate vaccination in the Netherlands, 2004 to 2015.
Wagenvoort GH; Sanders EA; Vlaminckx BJ; de Melker HE; van der Ende A; Knol MJ
Euro Surveill; 2017 Mar; 22(10):. PubMed ID: 28300529
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011.
Rudnick W; Liu Z; Shigayeva A; Low DE; Green K; Plevneshi A; Devlin R; Downey J; Katz K; Kitai I; Krajden S; Ostrowska K; Richardson D; Richardson S; Sarabia A; Silverman M; Simor AE; Tyrrell G; McGeer A;
Vaccine; 2013 Dec; 31(49):5863-71. PubMed ID: 24099873
[TBL] [Abstract][Full Text] [Related]
38. Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme.
Ingels H; Rasmussen J; Andersen PH; Harboe ZB; Glismann S; Konradsen H; Hoffmann S; Valentiner-Branth P; Lambertsen L;
Vaccine; 2012 Jun; 30(26):3944-50. PubMed ID: 22504662
[TBL] [Abstract][Full Text] [Related]
39. The status of invasive pneumococcal disease among children younger than 5 years of age in north-west Lombardy, Italy.
Riva E; Salvini F; Garlaschi ML; Radaelli G; Giovannini M
BMC Infect Dis; 2012 May; 12():106. PubMed ID: 22554011
[TBL] [Abstract][Full Text] [Related]
40. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine.
Poehling KA; Talbot TR; Griffin MR; Craig AS; Whitney CG; Zell E; Lexau CA; Thomas AR; Harrison LH; Reingold AL; Hadler JL; Farley MM; Anderson BJ; Schaffner W
JAMA; 2006 Apr; 295(14):1668-74. PubMed ID: 16609088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]